Evofem Inc.: Clinical Trials

6 trials sponsored by Evofem Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Terminated 1
Phase 21Completed 1

Follow Evofem Inc.: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
EVO100, Placebo - Sexually Transmitted Diseases, Gonorrhea
Phase 3CompletedEvofem Inc.18922020-10-152024-01-30
Phase 2B/3 Double-blinded Placebo-controlled
EVO100, Placebo - Chlamydia Trachomatis Infection
Phase 2 / Phase 3CompletedEvofem Inc.8602017-11-032020-08-12
AMP002 Phase III Contraceptive Study
AMPHORA - Contraception
Phase 3CompletedEvofem Inc.13842017-07-242020-09-17
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
LIPO-202, Placebo - Central Abdominal Bulging
Phase 3TerminatedEvofem Inc.1002015-06-012019-12-10
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
LIPO-202, Placebo - Central Abdominal Bulging
Phase 3CompletedEvofem Inc.7932015-04-092019-01-07
Study of Contraceptive Efficacy & Safety of Phexxiâ„¢ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel
Conceptrol, Amphora - Contraception
Phase 3CompletedEvofem Inc.33892011-04-012022-07-12

Conditions studied

Chlamydia Infections (1)  ·  Gonorrhea (1)  ·  Sexually Transmitted Diseases (1)

Interventions

Nonoxynol (1)  ·  Salmeterol Xinafoate (1)

Countries

United States (5)  ·  Russia (1)

Top investigators

Kelly Culwell, MD (2)  ·  Maria Feldman (2)  ·  Catherine Maher, PhD (1)  ·  Kelly Culwell (1)

Results publications

PMID 33705748, PMID 35418329